Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology, talks about innovations in gastroenterology technology.
While there aren't many widely-used digital therapeutics in gastroenterology yet, there are many other tehnologies like virtual reality that are growing more and more popular in the field, said Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology.
Transcript
How are digital therapeutics being used in gastroenterology?
I think gastroenterology is not as much exposed to digital therapeutics yet, but there are several upcoming companies that are using various modes. We now know that virtual reality can help with pain, irritable bowel syndrome [IBS], those kinds of things. So, those technologies will probably come up for commercial use in the near future. That's in terms of VR [virtual reality] kind of things.
From a measurement standpoint, right now we have some innovation happening in the IBD [inflammatory bowel disease] space, mostly. Because, if a patient has increased bowels, or we don't know if they're going into a flare, or it's their underlying IBS that's getting worse, you can actually have a kit for fecal calprotectin, which is a measure that we look at when we're looking at inflammation. That kit, you can do it at home. The patient doesn't need to come into the hospital. And you can use your smartphone to know the calprotectin level and that can communicate to your physician's office. You can say, "hey, the [calprotectin level] is high, so I think you are ill. So you need to come into the hospital," or something like that. So there are some technologies out there, but not really directly like a wearable, like Apple Watch, unless you're looking at the role of exercise or some other things for a disease outcome.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More